Register for the 7th RNAi-Based Therapeutics Summit
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in USD.
Register by Friday, October, 17 & Save up to $900
Drug Developer Pricing*
Conference + Workshop Day
(Save $900)
$3,297
On the Door: $4,197
Conference Only
(Save $500)
$2,499
On the Door: $2,999
Academic & Discounted Pricing**
Conference + Workshop Day
(Save $900)
$2,697
On the Door: $3,597
Conference Only
(Save $500)
$2,099
On the Door: $2,599
Service Provider Pricing***
Conference + Workshop Day
(save $900)
$4,197
On the Door: $5,097
Conference Only
(save $500)
$3,199
On the Door: $3,699
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when three or more delegates from one company book and pay at the same time.
10% Off
When registering 2Â attendees from one company
15% Off
When registering 3 attendees from one company
20% Off
When registering 4+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help in the booking process, contact us and one of the team will get back to you.
Explore the Full Event Guide
- 25+ expert speakers from pioneering biotechs and large pharma, including Sanegene Bio, AbbVie, Judo Bio, and more, sharing exclusive data and case studies.Â
- Actionable insights to conquer extrahepatic delivery for CNS, muscle, and cardiac tissues with novel strategies like aptamers, bispecifics, and exosomes.Â
- Dedicated deep-dives on the hottest applications: from obesity and metabolic disease to neurology, oncology, and the latest breakthroughs in microRNA therapeutics.Â
- Critical regulatory and CMC strategies to overcome complex synthesis, scale-up, and IND-enabling hurdles for late-stage clinical success.Â
- 8+ hours of dedicated networking with 80+ industry leaders to forge partnerships with key decision-makers from top RNAi innovators.Â
